NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan
· Delayed Price · Currency is TWD 19.50
-0.50 (-2.50%)
At close: Mar 9, 2026
TPEX:4732 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 917 | 1,230 | 1,343 | 1,737 | 2,534 | 1,207 | Upgrade
|
| Market Cap Growth | -18.83% | -8.42% | -22.70% | -31.42% | 109.96% | 5.06% | Upgrade
|
| Enterprise Value | 377 | 745 | 830 | 1,225 | 2,072 | 769 | Upgrade
|
| Last Close Price | 19.50 | 25.00 | 23.73 | 30.17 | 43.55 | 20.65 | Upgrade
|
| PE Ratio | - | 1371.24 | 132.72 | 57.87 | 82.24 | 18.47 | Upgrade
|
| PS Ratio | 5.08 | 5.48 | 8.39 | 7.60 | 10.14 | 3.93 | Upgrade
|
| PB Ratio | 1.28 | 1.57 | 2.12 | 2.71 | 4.06 | 2.02 | Upgrade
|
| P/TBV Ratio | 1.40 | 1.73 | 2.25 | 2.90 | 4.39 | 2.21 | Upgrade
|
| P/FCF Ratio | - | - | 21.70 | 125.42 | 75.14 | 22.10 | Upgrade
|
| P/OCF Ratio | - | - | 21.59 | 125.42 | 75.14 | 21.72 | Upgrade
|
| EV/Sales Ratio | 2.09 | 3.32 | 5.18 | 5.36 | 8.29 | 2.51 | Upgrade
|
| EV/EBITDA Ratio | - | - | 84.38 | 32.99 | 54.51 | 11.74 | Upgrade
|
| EV/EBIT Ratio | - | - | 241.67 | 46.51 | 76.80 | 13.28 | Upgrade
|
| EV/FCF Ratio | -16.70 | - | 13.41 | 88.45 | 61.45 | 14.09 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.56 | 0.07 | 0.17 | 0.04 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.13 | 0.20 | 0.20 | 0.05 | Upgrade
|
| Net Debt / Equity Ratio | -0.80 | -0.78 | -0.74 | -0.77 | -0.79 | -0.78 | Upgrade
|
| Net Debt / EBITDA Ratio | 15.25 | 109.75 | -47.53 | -13.23 | -12.92 | -7.16 | Upgrade
|
| Net Debt / FCF Ratio | 25.40 | 209.86 | -7.55 | -35.46 | -14.57 | -8.60 | Upgrade
|
| Asset Turnover | 0.24 | 0.29 | 0.23 | 0.33 | 0.37 | 0.49 | Upgrade
|
| Inventory Turnover | 1.16 | 1.25 | 1.02 | 1.71 | 2.22 | 2.93 | Upgrade
|
| Quick Ratio | 10.30 | 13.35 | 9.81 | 13.03 | 8.24 | 10.67 | Upgrade
|
| Current Ratio | 11.89 | 15.28 | 11.55 | 14.52 | 9.12 | 11.54 | Upgrade
|
| Return on Equity (ROE) | -7.05% | -0.51% | 1.59% | 4.74% | 5.04% | 11.55% | Upgrade
|
| Return on Assets (ROA) | -3.70% | -0.98% | 0.31% | 2.36% | 2.47% | 5.72% | Upgrade
|
| Return on Invested Capital (ROIC) | -30.38% | -7.10% | 2.17% | 18.60% | 20.59% | 43.62% | Upgrade
|
| Return on Capital Employed (ROCE) | -6.10% | -1.50% | 0.50% | 4.10% | 4.20% | 9.50% | Upgrade
|
| Earnings Yield | -4.04% | 0.07% | 0.75% | 1.73% | 1.22% | 5.41% | Upgrade
|
| FCF Yield | -2.46% | -0.24% | 4.61% | 0.80% | 1.33% | 4.52% | Upgrade
|
| Dividend Yield | - | - | 0.84% | 1.66% | 0.69% | 0.46% | Upgrade
|
| Payout Ratio | - | 1098.88% | 243.53% | 49.25% | 15.09% | - | Upgrade
|
| Buyback Yield / Dilution | 1.14% | 0.15% | -0.85% | -0.30% | 0.05% | -30.58% | Upgrade
|
| Total Shareholder Return | 1.14% | 0.15% | -0.01% | 1.36% | 0.74% | -30.12% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.